Kinesis: Venn Life Sciences bags profitable Dutch consultancy

Venn Life Sciences LONVENN is to raise £3.75mln through a placing of shares to part fund the 6.5mln acquisition of Kinesis Pharma BV.Venn said there was strong demand for its shares which have been placed at 22p each compared to last night's closing price...